We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Warner Chilcott, Mayne Score Win In Doryx ‘Product Hopping’ Case
Warner Chilcott, Mayne Score Win In Doryx ‘Product Hopping’ Case
Nearly three years after generics giant Mylan accused Warner Chilcott and Mayne Pharmaceuticals of “product hopping” with their acne medication Doryx, a federal judge has dismissed the case, ruling in favor of the brandmakers.